Histrelin acetate
CAS No. 220810-26-4
Histrelin acetate( Histrelin acetate(76712-82-8 free base) )
Catalog No. M29587 CAS No. 220810-26-4
Histrelin acetate is a nonapeptide analog of gonadotropin-releasing hormone (GnRH) with added potency. It acts on particular cells of the pituitary gland called gonadotropes when present in the bloodstream. Histrelin stimulates these cells to release luteinizing hormone and follicle-stimulating hormone. Thus it is considered a gonadotropin-releasing hormone agonist or GnRH agonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 169 | In Stock |
|
| 10MG | 275 | In Stock |
|
| 25MG | 465 | In Stock |
|
| 50MG | 638 | In Stock |
|
| 100MG | 901 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHistrelin acetate
-
NoteResearch use only, not for human use.
-
Brief DescriptionHistrelin acetate is a nonapeptide analog of gonadotropin-releasing hormone (GnRH) with added potency. It acts on particular cells of the pituitary gland called gonadotropes when present in the bloodstream. Histrelin stimulates these cells to release luteinizing hormone and follicle-stimulating hormone. Thus it is considered a gonadotropin-releasing hormone agonist or GnRH agonist.
-
DescriptionHistrelin acetate is a nonapeptide analog of gonadotropin-releasing hormone (GnRH) with added potency. It acts on particular cells of the pituitary gland called gonadotropes when present in the bloodstream. Histrelin stimulates these cells to release luteinizing hormone and follicle-stimulating hormone. Thus it is considered a gonadotropin-releasing hormone agonist or GnRH agonist.
-
In Vitro——
-
In Vivo——
-
SynonymsHistrelin acetate(76712-82-8 free base)
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number220810-26-4
-
Formula Weight1383.55
-
Molecular FormulaC68H90N18O14
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 100 mg/mL
-
SMILESCCNC([C@@H]1CCCN1C([C@H](CCCNC(N)=N)NC([C@H](CC(C)C)NC([C@@H](CC2=CN(C=N2)CC3=CC=CC=C3)NC([C@H](CC4=CC=C(C=C4)O)NC([C@H](CO)NC([C@H](CC5=CNC6=CC=CC=C65)NC([C@H](CC7=CNC=N7)NC([C@@H]8CCC(N8)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O.CC(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
PI-55
PI-55 (6-(2-hydroxy-3-methylbenzylamino)purine) is a cytokinin receptor inhibitor that exhibits structural similarity to 6-benzylaminopurine (BAP).
-
HQL-79
HQL-79, a potent, selective and orally active human hematopoietic prostaglandin D synthase (H-PGDS) inhibitor, highly selectively inhibits the synthesis of PGD2, and acts as an anti-allergic agent, with a Kd of 0.8 μM and an IC50 of 6 μM. Shows no obvious effect on COX-1, COX-2, m-PGES, or L-PGDS.
-
FGF basic (119-126) ...
bFGF (119-126) is a biological active peptide. (This peptide corresponds to human, bovine (119-126), mouse, rat (118-125) and Heparin-Binding Growth Factor 2 (118-125) residues of bFGF. It inhibits dimerization and activation of bFGF receptors.)
Cart
sales@molnova.com